Trials / Withdrawn
WithdrawnNCT01557933
Effects of Electroconvulsive Therapy (ECT) in Bipolar Depression
A Study of the Acute and Chronic Effects of Electroconvulsive Therapy on Glutamatergic Neurotransmission in Bipolar Depression
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Mclean Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to use magnetic resonance spectroscopy (MRS) to measure the levels of several brain chemicals including, but not limited to, glutamate, glutamine, and N-acetylaspartate, before and after treatment with ECT. In addition to MRS, the investigators will use several other MRI techniques including structural MRI, resting state functional MRI (fMRI), and diffusion tensor imaging (DTI) to measure how the structure and function of the brain changes with ECT. The investigators hypothesize that the Gln/Glu ratio is increased in the anterior cingulate cortex (ACC), but not the parieto-occipital cortex (POC), following the first ECT treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No interventions will be used | No interventions will be used |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2012-03-20
- Last updated
- 2012-11-29
Source: ClinicalTrials.gov record NCT01557933. Inclusion in this directory is not an endorsement.